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Recent  experimental  studies  have  shown  that  the  local  binding  of circulating 
antibody with antigens existing or planted within the glomerulus can result in damage 
to this structure  (1-6). In particular,  chemically cationized proteins are able to bind 
to the glomerular basement membrane  (GBM), act as a  planted antigen, and induce 
in situ immune complex formation accompanied by marked proteinuria  (4-6). Nega- 
tively charged components in the GBM (7-10) and on the surfaces of endothelial and 
epithelial  cells  (11-14)  act  as  a  barrier  to the  passage  of anionic,  but  not  cationic 
macromolecules  (15,  16).  These  fixed  anionic  sites  also  function  as  receptors  for 
cationic substances, and this is the basis of the system developed. 
We  describe  the  first  detailed  quantitative  studies  in  a  model  of in situ  immune 
complex nephritis that uses a cationic antigen, cationized human immunoglobulin G 
(IgG). The correlation between  the degree of proteinuria  and the amount of kidney 
fixing antigen and antibody was investigated.  In addition, the distribution of cation- 
ized  antigen  within  the  organism  and  the  disappearance  kinetics  of antigen  and 
antibody from the kidney were analyzed. The results documented here provide insight 
into events occurring at a  molecular level during immune complex formation involv- 
ing cationic antigens, which is an essential step before attempting to extrapolate  the 
concept of charge-based complex localization to man. 
Materials  and Methods 
Rats.  All experiments were performed on male Wistar rats of body weight varying from 120 
to 150 g (Zentraltierzfichterei,  Hannover, Federal Republic of Germany). 
Preparation of Cationized Human IgG and Determination of the Isoelectric Point ( pI).  Cationization 
of human IgG was performed as described previously (5), based on the method of Danon et al. 
(17)  using  1-ethyl-3  (3-dimethylaminopropyl)carbodiimide  hydroehioride  (EDC)  (Sigma 
Chemical Co., St.  Louis, Mo.)  as activator and N,N-dimethyl-l,3-propanediamine  (DMPA) 
(Eastman  Kodak Co.,  Rochester,  N.  Y.)  as a  nucleophile  to replace  carboxyl groups.  2  ml 
DMPA was added to 40 ml distilled water, and the pH was adjusted to 6.5 with  1 N HC1. 1.6 
g human IgG (10 ml Beriglobin, Behringwerke, F. R. G.) and 3 g EDC were added under mild 
stirring.  The  pH  was  maintained  at  6.5  for  6-8  h  in  a  TTT  60  Titrator  (Radiometer, 
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Copenhagen,  Denmark)  using 0.2 N  HCl. The reaction mixture was left overnight at room 
temperature, dialyzed against six changes of phosphate-buffered saline (PBS) in the cold, sterile 
filtered through a  millipore filter (0.45 #m), and stored at 4°C until required. The degree of 
cationization was estimated from isoelectric focusing in a slab gel system (Desaga, Heidelberg, 
F. R. G.). The reaction conditions given produced eationized human IgG with a pI exceeding 
9.5, and this was used throughout the study. To check for the presence of aggregated material, 
the cationized human IgG was run on 7.5% polyacrylamide gel using a basic gel system (18). 
Staining  with  amidoschwarz  indicated  that  the  cationized  preparation  consisted  of 90% 
monomer,  ~5% dimer, and  1-2% larger polymers. Analysis by gel column filtration was less 
satisfactory, because the material apparently interacts with the gel matrix, as reported by other 
workers (15). 
Antisera.  Antisera to human IgG were raised in rabbits by repeated injections of antigen in 
completed Freund's adjuvant. All anti-human IgG antibody used was from a single pool, with 
an  antigen-binding capacity of 1280  #g/ml,  measured  by  the  P-80  method  (19).  The  IgG 
fraction of this pool was isolated by repeated ammonium sulphate precipitation. 
Radiolabeling.  Cationized human IgG and the IgG fraction of rabbit anti-human IgG were 
labeled with l~I and laXI,  respectively, by the chloramine-T method (20). Labeled preparations 
in which >95% of the isotope was protein bound were used. The specific activity was 1 ×  10  7 
to 3 ×  107 cpm/mg of l~I-labeled cationized human IgG and 3 ×  106 to 4 ×  105 cpm/mg of 
~31I-labeled anti-human  IgG. Before use,  the preparation was  diluted with  the  appropriate 
amount of unlabeled material that had been treated with chloramine-T. Total amounts of t25I- 
labeled cationized human IgG injected were equivalent to 6 ×  104 to 8 ×  104 cpm/animal, and 
in the case of Ia~I-labeled anti-human IgG an equivalent of 1 ×  105 to 1.5 ×  l0  b cpm/animal 
was  injected. Radioactivity was  determined  in  a  well-type gamma  counter  Berthold, 7547 
Wildbad, F. R. G. (LB MAG 3/2; Berthold, Wildbad, Federal Republic of Germany). 
Unilateral Renal Perfusion.  A number 23 needle (Record) was used to canulate the left renal 
artery, and the left kidney was perfused with 0.5 ml PBS, followed by the test material in a 
volume of 0.2 ml, both at a  rate of 0.5 ml/min, after which the tubing was flushed with an 
additional 0.1 ml PBS. The period of ischemia ranged from 4 to 7 min. 
Estimation of Proteinuria.  24-h urinary specimens were collected in metabolic cages, centri- 
fuged at 1000 g for 10 min, and the protein content was measured with the biuret method (21) 
using human serum albumin as standard. 
Histological Examination.  For light microscopy, renal tissue was fixed in buffered formalin, 
embedded in paraffin, and 4-#m sections were stained with hematoxilin-eosin, periodic acid- 
Schiff, or periodic acid silver methamine. For immunofluoreseence, material was snap-frozen in 
n-hexane cooled to -70°C. Frozen sections were stained with monospecific fluorescein isothio- 
cyanate (FITC)-conjugated anti-human IgG (Behringwerke), anti-rabbit IgG, anti-rat IgG, and 
anti-rat C3 (Nordic Immunochemicals, Tilberg, Holland). Tissue fixed with 2.5% glutaralde- 
hyde in 0.1 M phosphate buffer (pH 7.4) was processed for electron microscopy as described by 
Zollinger and Mihatsch (22). 
Experimental Design.  Five groups of experiments were performed according to the following 
schedules; three to five rats were used per experiment at each time point studied. 
l.  DISTRIBUTION OF CATIONIZED HUMAN IgG At~rER  INTRAVENOUS INJECTION.  Rats were given 
I mg of 125I-labeled cationized human IgG in I mt PBS and killed 1 h later, and the activity in 
the left and right kidney and in samples of blood, spleen, liver, lung, and heart was determined. 
2.  DISTRIBUTION OF CATIONIZED HUMAN  ]gG  AFTER  INTRARENAL  INJECTION.  The left kidneys 
of rats  were  perfused  with  5-200  ktg of 125I-labeled  cationized human  IgG.  Samples were 
measured as in experiment 1. 
3.  NEPHRITOGENIC POTENTIAL OF CATIONIZED HUMAN IgG PLANTED IN THE GLOMERULUS AFTER 
INTRAVENOUS ADMINISTRATION  OF ANTI-HUMAN  IgG ANTISERUM.  5-100 /tg of cationized human 
IgG was perfused directly into the left kidney via the renal artery.  1 h  later, the rats were 
injected with 0.5 ml rabbit anti-human IgG antiserum intravenously. As controls, the following 
two experiments were done: (a) perfusion of 100 ~g of normal human IgG, followed by 0.5 ml 
of anti-human IgG intravenously 1 h later; and (b) perfusion of 50/~g ofcationized human IgG, 
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daily for a period of up to 4 wk. Renal tissue was taken for immunofluorescent study at intervals 
between 1 h and 3 too, and for light and electron microscopy between 1 d and 3 too. 
4.  DEGREE OF BINDING OF ANTI-HUMAN IgG ANTIBODY TO A PREVIOUSLY PLANTED, NEPHRITOGENIC 
DOSE OF CATIONIZED  HUMAN Ig~.  A  group of rats  were  perfused with  20 Rg of cationized 
human IgG (for selection of dose, see Results) into the left renal artery, and 2 h later 1.0-10 mg 
of 131I-labeled anti-human IgG antibody globulin was given intravenously. 72 h later, rats were 
killed,  and the quantity of anti-human IgG in each kidney was determined. For controls, rats 
were perfused via the left renal artery with 20 #g of native human IgG, and 1 h later were given 
2.5  mg of 131I-labeled anti-human  IgG antibody  globulin  intravenously;  second,  rats  were 
injected with 2.5 mg of 181I-labeled normal rabbit IgG 1 h after perfusion of the left kidney with 
20 pg of cationized human IgG. The value for renal binding of 131I-anti-human  IgG in the left 
kidney was corrected  for blood contamination by deducting the counts  found in  the right 
kidney. Binding of anti-human IgG to the cationized human IgG localized in the kidneys was 
also checked for by immunofluorescence. For these experiments, rats were perfused with up to 
100/~g of cationized human IgG into the left renal artery, followed by intravenous injection of 
0.5 ml of anti-human IgG 1 h later, and were killed  1 h after injection. As a control, normal 
rabbit serum was substituted for the anti-human IgG antiserum. 
5.  DISAPPEARANCE KINETICS OF CATIONIZED HUMAN IgG FROM  THE KIDNEY AFTER INTRAVENOUS 
INJECTION.  Rats were given  I  mg l~SI-labeled cationized human IgG via the tail  vein. The 
animals were killed  1, 3, 6,  12, 24, 48, and 72 h after injection, and the amount of cationized 
human IgG localized in the kidneys was measured. 
6.  DISAPPEARANCE KINETICS OF CATIONIZED HUMAN IgG PERFUSED DIRECTLY INTO LEFT KIDNEY 
AND EFFECT OF SUBSEQUENT ADMINISTRATION OF ANTIBODY.  43  rats were perfused  with  20 big of 
125I-labeled cationized human IgG each into the left kidney. Groups of three to five rats were 
killed  i  h or I, 3, and 5 d later.  In the remaining 28 rats,  2.5 mg of rabbit anti-human IgG 
antibody was injected intravenously I h after the antigen, and they were killed  l  h or I, 2, 3, 
5, 7, 14, and 21 d later.  Renal binding of cationized human IgG was measured in all animals. 
7.  DISAPPEARANCE KINETICS OF ANTI-HUMAN IgG ANTIBODY FROM THE KIDNEY.  IN situ immune 
complex formation was induced by unilateral  perfusion of 20 p,g of cationized human IgG, 
followed by intravenous injection of 2.5  mg of lnlI-labeled rabbit  anti-human IgG antibody 
globulin; these conditions produced glomerulonephritis. Rats were killed  after 1 h and on days 
1, 2, 3, 5, 7, 14, and 21, and renally bound antibody was measured. 
Results 
1.  Distribution of Cationized Human IgG after Intravenous Administration.  The distribu- 
tion of cationized human IgG 1 h after intravenous injection is shown in Fig.  1, which 
is ~20 pg (2%)  of the total dose injected  (1  mg) localized per kidney. The major site 
of antigen localization was the liver (20%). 
2.  Distribution of Cationized Human  IgG after Perfusion into the  Left Kidney.  Results 
obtained  1 h  after perfusion  (Table  I) showed that,  with doses of between  5 and 50 
/~g cationized human IgG, the amount bound to the left kidney increased linearly and 
was "-50% of the total injected. In the right kidney a maximum of 0.5% of the injected 
dose  was  present  (blood contamination  presumably  contributed  to this  value  [Fig. 
2]).  In the cases of doses of 100 and  200 #g cationized  human  IgG, the  fraction of 
antigen localizing in the perfused kidney fell to 33 and 23%, respectively. In parallel, 
the  amount  of antigen  present  in  the  right  kidney increased,  reaching  2.2%  of the 
total  injected, equivalent  to a  maximum of 12.5%  of the quantity  found in the left 
kidney. 
Positive fluorescence along the GBM was confined to the left kidney with a dose of 
up to  100 ~g of cationized  human  IgG. The interstitium  was negative.  A  dosage of 
200/~g resulted  in positive immunofluorescence in the right kidney as well.  Positive 
interstitial  staining  was  observed  in  the  left  kidney.  Fig.  2  shows  the  whole  body OITE  ET  AL.  463 
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FIG.  1.  Distribution of catlonized human IgG given intravenously. Three rats were each injected 
with  1 mg 12~I-cationized  human  IgG in  1 ml PBS via the tail vein, killed -1  h later, and the 
activity in the various samples was measured. 
TABLE  I 
Amounts of z251-cationized Human IgG Bound to Perfused Kidney * 
1251-cationized 
human IgO 
infused 
125I-cationized  human IgG 
Left kidney  Right kidney 
ttg  #g/kidney 
5  2.4 ±  0.9:~  (48)§  0.01 4- 0.003:~ (0.2)§ 
10  5.6 ±  0.4  (56)  0.03 ± 0.001  (0.3) 
20  11.1 ±  0.8  (56)  0.07 ± 0.02  (0.4) 
50  22.6 ±  4.4  (45)  0.24 4- 0.03  (0.5) 
100  33.3 ±  10.6  (33)  0.64 ± 0.20  (0.6) 
200  45.8 ±  19.4  (23)  4.46 ± 2.16  (2.2) 
* Rats were killed 1 h after perfusion. 
~: Mean + SD of three to five rats. 
§ Percentage of dose injected, mean of three to five rats. 
distribution of cationized human  IgG after perfusion of 20/~g of antigen into the left 
kidney. The perfused kidney contained 56% of the total dose injected, compared with 
2% after intravenous application (see above). 
3.  Nephritogenic Potential  of Cationized Human  IgG  Planted  in  the  GBM after Passive 
Administration of Anti-Human IgG Antiserum.  These experiments were performed with 
a  standard volume of antiserum  (0.5 ml), which had an antigen-binding capacity of 
640 pg. The degree of proteinuria induced depended on the dose of cationized human 
IgG previously administered.  10 ~g of antigen or less produced  a  mild proteinuria, 
and rats given 20/lg or more of cationized human  IgG developed a  severe glomeru- 
lonephritis, with a  proteinuria of at least  100  mg/24  h. The time of onset as well as 
the persistence of proteinuria depended on  the dose of antigen  perfused  (Table II). 
No abnormal proteinuria was observed in control experiments. 
Immunofluorescence revealed deposition of human  IgG and rabbit IgG along the 
glomerular capillary wall (Fig. 3 a, b). These deposits appeared confluent on the first 
2  d  (Fig. 4 a)  and  became more granular during the course of the disease (Fig. 4 b). 
Moderate staining for rat C3 was seen at  1 h  (the earliest time tested) and remained 464  IMMUNE  COMPLEX  NEPHRITIS  INDUCED  BY CATIONIZED  ANTIGEN 
c  o 
+i  10" 
E  2 
z~ 
-  g 
~5 
q- 
Blood  i-  r-  Spleen  Heart 
(l ml)  Kidney  kxdney 
Liver  r-Luog 
•  25 
Fio.  2.  Distribution of cationized human IgG perfused via the renal artery. The left kidneys of 
•  125  -  ,  four rats were each perfused with 20/Lg  I-cattomzed human IgG.  1 h later rats were killed,  and 
activity in the various samples was measured. 
TABLE  II 
Nephritogenic Potency of Renally Bound, Cationized Human IgG, after Passive 
Administration of Excess of Anti-Human IgG Antiserum 
Unilateral 
renal 
perfusion* 
Intravenous injection  S 
Average mg urinary protein per 24 h§ 
Day l  Day 2  Day 3  Day 5  Day 7  Day 14 
5 #g cationized  0.5  ml anti-human  5.0  3.9  14.2  22.4  37.8  9.4 
human IgG  IgG (rabbit) 
10/~gcationized  0.5 ml anti-human  8.2  4.5  7.2  18.7  32.9  10.9 
human IgG  IgG (rabbit) 
20/~gcationized  0.5  ml anti-human  3.8  77.4  93.0  158.5  107.2  13.1 
human IgG  IgG (rabbit) 
50~gcationized  0.5  ml anti-human  2.3  78.3  246.7  231.8  216.8  44.5 
human IgG  IgG (rabbit) 
100  #g  cation-  0.5 ml anti-human  69.0  115.0  214.0  246.6  229.0  102.0 
ized  human  IgG (rabbit) 
IgG 
50/zg cationized  0.5 ml normal  1.0  3.0  5.6  2.0  4.5  6.6 
human IgG  rabbit serum 
100  #g  normal  0.5 ml anti-human  3.3  4.9  3.9  8.2  6.6  NDII 
human IgG  IgG (rabbit) 
* Rats were perfused with cationized human IgG in a volume of 0.2 mI via the left renal artery. 
I: Rats were injected through the tail veins 1 h after perfusion. 
§ Average of three to five rats. 
[] Not determined. 
fairly constant  within  the first 2  wk,  declining thereafter. The  pattern  was similar to 
that  of  the  human  IgG.  Complement  deposition  clearly  preceded  development  of 
proteinuria.  Rat  IgG was detectable  in the capillary walls  from approximately  day  7 
onwards.  By this time the proteinuria  was declining, and a  second phase was not seen. 
Electronmicroscopy  revealed  a  prominent  accumulation  of electron  dense  deposits, 
mainly  in the subepithelial space and  beneath  slit pores  (Fig.  5). These were already OITE ET AL.  465 
F~o.  3.  Cryostat sections of rat glomeruli. (a) Stained with fluoreseein isothiocyanate (FITC) anti- 
human IgG. 100/ag of cationized human IgG was perfused via the renal artery and rat was killed 
1 h later. Glomerular localization of human IgG was seen along the capillary walls (× 200). (b) 
Stained  with  FITC anti-rabbit-IgG.  Perfusion of 100 #g of cationized human IgG followed by 
passive injection of rabbit anti-human  IgG and killing 15 min later. Rabbit  IgG was found along 
the capillary walls in a pattern identical to human IgG (c,f. Fix. 3a) (× 200). 
visible on day 1, the earliest time point investigated. Glomerular hypercellularity was 
not pronounced. 
4.  Binding of Anti-Human IgG Antibody to  Planted Cationized Human IgG.  20  #g  of 
cationized  human  IgG  was  chosen  for  these  experiments  (see  Table  II),  and  a 
minimum of 2.5 mg of 131I-labeled anti-human IgG had to be injected intravenously 
to regularly induce proteinuria. In absolute values, 35.9/~g of antibody IgG was found 
in the left kidney on day 3, whereas only 4.0 ~g was found in the right kidney, giving 
a  corrected  uptake  of 31.9/~g  in  the  left  kidney  (see  Materials  and  Methods).  The 
quantity of 131I-labeled anti-human  IgG antibody bound to the left kidney increased 
with  the quantity of anti-human  IgG injected  (Table  III). The activity in  the right 466  IMMUNE  COMPLEX  NEPI-IRITIS  INDUCED  BY  CATIONIZED ANTIGEN 
Flc.  4.  Cryostat  sections of rat  glomeruli.  (a)  stained  with  FITC anti-human  lgG.  I  d  after 
perfusion of 100 #g cationized human IgG, followed by passive injection of rabbil anti-human IgG 
serum, human IgG appears  to localize almost continuously along the capittary loops (X 150). (b) 
Stained with FITC anti-rabbit IgG. Left kidney was perfused with 100 #g of cationized human IgG, 
followed by passive injection  of anti-human IgG antiserum.  10 d  later rat  was killed. Discrete 
granular deposition of rabbit IgG was seen along the capillary loops (× 200). 
kidney corresponded to contamination with -0.1  ml blood (Table III), an acceptable 
estimate confirming the suitability of the formula used. 
5.  Disappearame Kinetics of Intravenously Administered 125I-labeled Cationized Human IgG 
from the Kidney.  The rate of removal of intravenously injected 12~I-labeled cationized 
human  lgG from  the  kidneys is shown  in  Table IV.  21.1  and  20.6 #g of cationized 
human IgG were bound in the left and right kidneys, respectively, 1 h  after injection. 
There followed a  relatively rapid decrease up to 6  h, with a  subsequently slower rate 
of disappearance. 
6.  Disappearance Kinetics of Cationized Human IgG Perfused Directly into Left Kidney and 
Effect of Subsequent Administration of Antibody.  Fig. 6  shows the disappearance kinetics 
ofcationized human IgG from the perfused kidney with and without passive injection OITE ET AL.  467 
Fla.  5.  The electron microscopic  appearance of a glomerulus from a rat 3 d after perfusion of 20 
gg cationized human IgG followed by intravenous injection of anti-human IgG.  Massive  subepithe- 
lial electron dense deposits are present (× 39,000). 
of antibody. There was a  remarkable difference between the removal rates of antigen 
in  both  groups.  After  perfusion  with  20 #g  of t25I-labeled  cationized  human  IgG, 
antigen disappeared from the kidney just as rapidly as in the case of 1.0 mg of antigen 
given  intravenously.  In  contrast,  a  significant  proportion  of the  cationized  human 
IgG was removed more slowly from the perfused kidney when 2.5 mg of anti-human 
IgG antibody globulin had been given subsequently.  1.3 #g of cationized human IgG 
was still fixed to the perfused kidney on day 21.  From the results shown in Fig. 6, it 
could be calculated that -  12 d were needed until one-half of the 125I-labeled  cationized 
human IgG, fixed on day 1, had been removed from the perfused kidney. 
7.  Disappearance Kinetics of laal-labeled Anti-Human  lgG Antibody from  the Kidney after In 
Situ  lmmune  Complex Formation at Nephritogenic Levels.  After in situ  immune complex 
formation  at  nephritogenic  levels  (perfusion  of 20  #g  of cationized  human  IgG, 
intravenous  injection  of 2.5  mg xaaI-labeled anti-human  IgG), the  amount  of anti- 
human IgG antibody in the perfused kidney remained almost unchanged during the 
first week. A  more marked loss of antibody from the kidney was seen between days 7 
and  14 (Fig. 7). 468  IMMUNE  COMPLEX  NEPHRITIS  INDUCED  BY  CATIONIZED  ANTIGEN 
TABLE  III 
Amount of Anti-Human IgG Injected to Induce Proteinuria * 
Activity 
Rabbit  1311-  in right  Number 
kidney 
Rabbit l~lI-anti-  Rabbit 131I-  Rabbit lz1I-  anti-human  Rabbit lzaI-  in  exhibit- 
human Ig,  G  in-  anti-human  anti-human  IgG bound to  anti-human  equiva-  ing pro- 
jected  IgG in left  IgG in right  left kidney  IgG in blood  lents of  teinuria 
kidney  kidney  (minus right  blood  >30 
kidney)  contam-  mg/d:~ 
ination 
rag  p,g  ~tg  ~g  I~g/ral  ml 
1,0  15.0 ±  3.7§  1.8 4- 0.2  13.2 4-  1.8  22.5 4- 1,8  0.08  1/3 
2.5  35.9 ±  5.0  4.0 ±  0.9  31.9 4- 5,7  44.9 ±  8.3  0.09  4/4 
5,0  92.5 :t:  17.7  9.2 4- 3.1  83.3 ±  19.1  104,4 4- 13.5  0.09  3/3 
10.0  199.1  ±  24.3  20.8 4- 14.3  178.2  4- 24,2  221.3 +  75.2  0.09  3/3 
Control 
2.511  12.3 4- 1.9  8.6 +  0.5  3.7 4-  1.9  66.3 4-  10.3  0.13  0/4 
2.5 mg of normal  8.6 ±  2.6¶  6.9 4- 0.3¶  2.3 4- 2.1¶  55.4 4- 5.6¶  0.12  0/3 
rabbit IgG 
* Rats were injected with anti-human IgG 1 h after renal perfusion with 20/tg cationized human IgG and 
killed on day 3, and uptake of 131I-anti-human IgG antibody globulin was determined. 
:~ Estimated on day 3. 
§ Mean ±  SD. 
]1 Rats were perfused with 20/zg native human IgG. 
¶ Amounts of 131I normal rabbit IgG. 
TABLE IV 
Disappearance of Intravenously Injected Cationized  Human IgG from the 
Kidney 
Time 
12Sl-cationized human ]gG bound* 
Left kidney  Right kidney 
h  l.,tg/kidney 
1  21.1  4- 3.L~  20.6 4- 13 
3  13.9 4- 0,8  13.8 4- 16.2 
6  6.94-0.8  7.1 4-0.7 
12  3.7 4- 0.3  3.6 ±  0.2 
24  1.6 4- 0.2  2.0 4- 0.2 
48  1.2 4- 0.2  1.3 4- 0.1 
72  1.1 4- 0.2  1.1 4- 0.2 
* Rats were injected with 1 mg of 12%cationized human IgG through the tail 
vein. 
:1: Mean 4- SD of three rats. 
Discussion 
The  idea  that  the  deposition  of circulating immune complex in  the  glomerular 
filtration harrier could be an initiating event in glomerulonephritis was unchallenged 
for  many  years.  This  consensus  was  derived  from  detailed  analysis  of acute  and 
chronic  serum  sickness  models  (23,  24).  In  particular,  subepithelial  depbsits  were 
thought to be formed by this route in addition to the frequently occuring subendo- 
thelial and  mesangial  immune deposits. The earlier suggestion that  serum  sickness OITE  ET  AL.  469 
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nephritis was caused by in situ formation of immune complex (25) was more recently 
revived to explain observations relating to subepithelial  deposit formation in  Hey- 
mann (1, 2) and Lupus nephritis (26). 
The probability of an in situ immune complex is more likely with antigens that can 
interact with structures of the GBM; cationic proteins fulfill this requirement  (4-6, 
15). An essential property of the GBM is the presence of discrete fixed anionic sites in 
the lamina tara externa and  interna that  convey an overall negative charge to the 
membrane (9,  10,  14). Previous studies (4) demonstrated that intravenously injected 
cationic moieties bound to the GBM if their molecular weight did not exceed a critical 
value lying between  500,000  and  900,000  and  their pI was  >8.5-9.5.  Experiments 
employing the method of unilateral  renal perfusion showed that cationized human 470  IMMUNE  COMPLEX NEPHRITIS INDUCED BY CATIONIZED ANTIGEN 
IgG  and  cationized  horse  spleen  ferritin  can  act  as  planted  antigens  with  which 
circulating antibody can react to form an in situ immune complex and induce massive 
proteinuria  (5,  6).  In  this  investigation, quantitative analysis of such  a  model was 
undertaken to measure the minimum quantities of antigen and antibody necessary 
for induction  of kidney damage  as  well  as  to  determine the  fate of the  complex. 
Cationized human IgG was selected because ferritin cannot be stably radioiodinated 
in our hands. 
Cationized proteins localize throughout the body when injected intravenously, and 
under the conditions used here, -4% of the cationized human IgG was found in the 
kidneys.  This  is  explained by the  high  affinity of cationic substances  for negative 
charges  found  throughout  the  vascular  bed  and  on  blood  components,  such  as 
erythrocytes (17) or platelets (10).  Unilateral renal perfusion via the left renal artery 
was used to preferentially localize the test material into the kidney. Provided that 
<100/~g of antigen was perfused, no antigen could be detected in the unperfused 
kidney by immunofluorescence. Up to 56% of the injected dose was found in the left 
kidney after 1 h, and at this time <1% still circulated. This effectively excludes the 
possibility that a significant deposition of circulating immune complexes could occur 
after passive administration of antibody. The absolute quantity of cationized human 
IgG deposited in the kidney increased with dose, although the percentage localizing 
fell from  50/~g  downwards.  We believe that  saturation  of the  anionic sites  in  the 
GBM occurs and  that  additional  antigen  is localized elsewhere in  the kidney; the 
finding of positive interstitial fluorescence only with higher doses supports this view. 
Administration of as little as 20/xg of high cationized human IgG (pI >  9.5)  directly 
into the left renal artery and systemic injection of 2.5 mg of the IgG fraction of anti- 
human IgG  1 h  later regularly induced a  massive proteinuria in rats. This demon- 
strates clearly that only minimal amounts of antigen and antibody are necessary to 
cause  overt  kidney  disease.  At  the  time  of antibody  injection,  11.1  +  0.8  /~g  of 
cationized human IgG was initially planted in the perfused left kidney, and there was 
only 0.07/xg in the unperfused right kidney (0.6% of the dose in the left kidney). At 
the onset of proteinuria, ~4 ktg antigen and ~30/~g anti-human IgG antibody were 
present in the perfused kidney. It is interesting to compare the dose of antigen and 
antibody needed to induce renal damage in our model with those measured in other 
models of immunologic experimental glomerulonephritis. Relevant work concerning 
renal  injury induced by passively given antibody against  heterologous nephrotoxic 
gammaglobulin, which played the role of fixed antigen, was performed by Unanue 
and  Dixon  (27)  in  rats.  They  showed  that  12-40  /xg  of kidney-fixing  antibody 
(nephrotoxic antibody), which itself produced no proteinuria, had to be available as 
target antigen to induce proteinuria. In the model of one-shot serum sickness, a mean 
of 10/~g of bovine serum albumin (BSA) was deposited per kidney after elimination 
of BSA from the circulation (28). These values are of the same order as the quantity 
of cationic antigen required in our system. 
When administered alone the majority of the cationized human IgG was removed 
from the kidneys within hours. Initially, immunofluorescence showed the antigen to 
be distributed in a virtually linear pattern along the GBM, reflecting the high density 
of antigen  deposits.  With  time,  the  pattern  became  granular  in  nature  and  the 
intensity decreased, and by 24 h the glomeruli were mostly negative. 
After binding of antibody, the removal of antigen from the kidney was retarded, OITE ET AL.  471 
and  12  d  was  needed  to remove one-half of the cationized human  IgG.  With  the 
exception of the first 1 or 2 d, the immunofluorescent staining pattern for antigen and 
antibody was granular in nature. Deposition of rat C3 clearly preceded induction of 
proteinuria.  We have not  investigated whether complement is  essential  in  causing 
tissue damage in this system. Rat IgG was first observed after 7 d, when the proteinuria 
was  in  decline  and  no  second  phase  was  seen,  as  usually  occurs  in  nephrotoxic 
nephritis.  This  indicates  that  subsequent  fixation of rat  antibody  to  the  immune 
deposits has little influence on the course of the disease. Electron microscopy revealed 
massive subepithelial dense deposit formation showing great similarity to findings in 
some human glomerulonephritides. 
In  our  system  (cationic  antigen)  and  in  one-shot  serum  sickness  (28)  (anionic 
antigen), the antigens were removed from the kidneys with a similar half-life of 10-14 
d, indicating that the charge of the antigen had little influence on elimination from 
the complex. Cationized human  IgG was removed faster from the kidney than the 
antibody, the binding of which remained almost  unchanged during the first week. 
Perhaps the remaining circulating antibody continued to bind to deposited antigen 
or to the antigen-antibody complex in  the kidney, or antigen was  indeed removed 
faster than antibody from the immune complex. In addition, some antigen may be 
located  in  a  part  of the  kidney not  accessible  to  antibody and  may  therefore be 
eliminated independently. 
A difference in the disappearance of antigen and antibody has been described by 
Fish et al.  (29), who examined the course of one-shot serum sickness nephritis using 
immunofluorescence.  However, it  is  not  certain  that  a  real  difference exists  here, 
because it was proposed (28) that the antigen may be masked but still be present. The 
half-life of kidney-fixed gamma globulin in nephrotoxic nephritis of the rat has been 
reported to be 52 d (30). A direct comparison of these results is of doubtful value since 
the mode of binding with the glomerular capillary walls is different. 
Recent  studies  have  provided evidence that  in  situ  immune  complex formation, 
which  may  be  a  cause  of tissue  injury  in  various  organs  (31,  32),  can  result  in 
glomerular injury (1-6). In passive Heymans nephritis, it has been shown (1) that the 
GBM  contains  antigen  similar  to  F×IA,  found  in  the  brush  border of proximal 
tubular epithelial cells, either as intrinsic or planted antigen, which serves as a target 
for circulating antibody in the rat. Using heterologous antiserum, the total quantity 
of kidney-fixing antibody was shown to exceed 100 #g/kidney (33).  Proteinuria did 
not  usually  reach  a  level of >100  mg/d  from  both  kidneys  (2,  33).  In  our study, 
proteinuria from a single kidney exceeded 100 mg/d after the deposition of -30 #g of 
heterologous antibody before autologous rat IgG was detectable by immunofluores- 
cence.  Thus,  there  appear  to  be  quantitative  differences between  our  model  and 
passive Heymans nephritis,  although subepithelial dense deposits are prominent in 
both  cases  (2,  34).  The  glomerulus  has  other  features  that  may  promote  in  situ 
glomerular immune complex formation. Golbus and  Wilson used the glycoprotein- 
binding property of the lectin concanavalin A  (Con A) to plant it in the glomerular 
capillary wall. Systemic injection of anti-Con A antibodies resulted in in situ immune 
complex formation and proliferative glomerulonephritis (3).  In this latter model the 
proteinuria induced lay within the range of 16-51 mg/d. The site of immune complex 
formation seems to be on the endothelial side of the GBM, because binding of Con A 
could  be easily reduced by subsequent  perfusion of alpha-methyl-mannoside.  The 472  IMMUNE  COMPLEX  NEPHRITIS  INDUCED  BY  CATIONIZED ANTIGEN 
existence of complexes exclusively subendothelially may result in a less severe injury 
to the glomerular capillary wall. The mechanism of in situ complex formation is now 
seriously considered to operate in acute serum sickness nephritis, as experiments with 
isolated kidneys showed that alternating perfusion with BSA and anti-BSA resulted 
in subepithelial complex formation, whereas preformed immune complex failed to 
localize (35). 
Recently, data were presented (36) concerning the relationship between glomerular 
permeability and  the anionic  glycosaminoglycan (GAG).  In this work, the anionic 
component  GAG  in  the  lamina  rara  interna  and  externa  was  considered  to  be 
important in regulating the permeability of the glomerular capillary wall. The loss of 
these anionic sites following treatment with a specific enzyme, heparinase, remarkably 
enhanced both the penetration of native ferritin into the GBM and its excretion into 
the urinary space, whereas other enzymes such as hyaluronidase and chondroitinase 
ABC had no effect. The interaction of cationic antigen-antibody complex with the 
GBM could lead to a decrease or an alteration of the fixed anionic sites, resulting in 
a disturbance of glomerular permeability. 
Summary 
Cationized human IgG can bind to the rat glomerular basement membrane (GBM), 
act as planted antigen, and induce in situ immune complex formation accompanied 
by severe glomerulonephritis. Perfusion of highly cationized human IgG (isoelectric 
point >  9.5)  via the left renal artery resulted in preferential localization within the 
perfused kidney (up to 56% of dose injected); after intravenous administration, only 
4% was bound to the kidneys. The planted antigen was localized along the glomerular 
capillary walls and was accessible for antibody administered intravenously 1 h after 
perfusion, when virtually no antigen remained in the circulation. 
Persistence of cationized human IgG in the perfused kidney was markedly prolonged 
when complexed with antibody; one-half the cationized human IgG was still present 
after 12 d. There was a difference in the disappearance rates of antigen and antibody, 
as cationized human IgG was removed faster from the kidney than the antibody, the 
binding of which remained almost unchanged during the first week. Renal perfusion 
of a  minimum of 20 #g of cationized human IgG, followed by intravenous injection 
of antibody, regularly induced severe glomerulonephritis with a proteinuria of at least 
100 mg/24 h. The degree and the persistence of proteinuria induced depended on the 
dose of cationized human IgG perfused. 
Experiments  using  radiolabeled  antigen  and  antibody  showed  that  after  renal 
perfusion of 20/~g cationized human IgG,  11.1 #g was kidney bound at the time of 
antibody injection. At the onset of proteinuria, 4.0 #g of antigen and 31.9 #g of anti- 
human  IgG  antibody  were  present  in  the  perfused  kidney.  Immunofluorescence 
revealed immune deposits consisting of cationized human IgG and rabbit IgG (anti- 
human IgG) along the GBM. The staining pattern was linear (confluent) during the 
first 2 d  and  became granular during the course of the disease.  Electronmicroscop- 
ically, a  prominent  finding was  the accumulation of dense deposits, mainly in the 
subepithelial space and beneath the slit pores. 
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